MOXIFLOXACIN HYDROCHLORIDE tablet, film coated

País: Estados Unidos

Língua: inglês

Origem: NLM (National Library of Medicine)

Ingredientes ativos:

MOXIFLOXACIN HYDROCHLORIDE (UNII: C53598599T) (MOXIFLOXACIN - UNII:U188XYD42P)

Disponível em:

REMEDYREPACK INC.

Via de administração:

ORAL

Tipo de prescrição:

PRESCRIPTION DRUG

Indicações terapêuticas:

Moxifloxacin;tablets are indicated in adult patients for the treatment of Community Acquired Pneumonia caused by susceptible isolates of Streptococcus pneumoniae (including multi-drug resistant Streptococcus pneumoniae [MDRSP]) , Haemophilus influenzae, Moraxella catarrhalis, methicillin-susceptible Staphylococcus aureus, Klebsiella pneumoniae, Mycoplasma pneumoniae, or Chlamydophila pneumoniae [see Clinical Studies (14.3)] . MDRSP isolates are isolates resistant to two or more of the following antibacterial drugs: penicillin (minimum inhibitory concentrations [MIC] ≥ 2 mcg/mL), 2nd generation cephalosporins (for example, cefuroxime), macrolides, tetracyclines, and trimethoprim/sulfamethoxazole. Moxifloxacin;tablets are indicated in adult patients for the treatment of Uncomplicated Skin and Skin Structure Infections caused by susceptible isolates of methicillin-susceptible Staphylococcus aureus or Streptococcus pyogenes [see Clinical Studies (14.4)]. Moxifloxacin tablets are

Resumo do produto:

Moxifloxacin;Tablets, USP;are available as modified capsule shaped, dull red film-coated tablets containing 400 mg moxifloxacin. The tablet is debossed with E-18 on one side and plain on the other side. NDC: 70518-3738-00 PACKAGING: 7 in 1 BOTTLE PLASTIC Store at;20° to 25°C (68° to 77°F);[see USP Controlled Room Temperature].;Avoid high humidity. Repackaged and Distributed By: Remedy Repack, Inc. 625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762

Status de autorização:

Abbreviated New Drug Application

Folheto informativo - Bula

MOXIFLOXACIN HYDROCHLORIDE- MOXIFLOXACIN HYDROCHLORIDE TABLET, FILM
COATED
REMEDYREPACK INC.
----------
MEDICATION GUIDE
Moxifloxacin Tablets, USP
(mox'' i flox' a sin)
for oral use
Rx only
Read the Medication Guide that comes with moxifloxacin tablets before
you start taking them and each
time you get a refill. There may be new information. This Medication
Guide does not take the place of
talking to your healthcare provider about your medical condition or
your treatment.
What is the most important information I should know about
moxifloxacin tablets?
Moxifloxacin tablets is in a class of antibiotics called
fluoroquinolones. Moxifloxacin tablets can cause
serious side effects that can happen at the same time and could result
in death. If you get any of the
following serious side effects, you should stop taking moxifloxacin
tablets and get medical help right
away. Talk with your healthcare provider about whether you should
continue to take moxifloxacin tablets.
1. Tendon rupture or swelling of the tendon (tendinitis).
•
Tendon problems can happen in people of all ages who take moxifloxacin
tablets. Tendons are
tough cords of tissue that connect muscles to bones. Symptoms of
tendon problems may include:
•
Pain, swelling, tears and inflammation of tendons including the back
of the ankle
(Achilles), shoulder, hand, or other tendon sites.
•
The risk of getting tendon problems while you take moxifloxacin
tablets is higher if you:
•
Are over 60 years of age.
•
Are taking steroids (corticosteroids).
•
Have had a kidney, heart or lung transplant.
•
Tendon problems can happen in people who do not have the above risk
factors when they
take moxifloxacin tablets.
•
Other reasons that can increase your risk of tendon problems can
include:
•
Physical activity or exercise.
•
Kidney failure.
•
Tendon problems in the past, such as in people with rheumatoid
arthritis (RA).
•
Stop taking moxifloxacin tablets immediately and call your healthcare
provider right away at the
first sign of tendon pain, swelling or

Características técnicas

MOXIFLOXACIN HYDROCHLORIDE- MOXIFLOXACIN HYDROCHLORIDE TABLET, FILM
COATED
REMEDYREPACK INC.
----------
HIGHLIGHTS OF PRESCRIBING INFORMATION
THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE
MOXIFLOXACIN TABLETS
SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR
MOXIFLOXACIN TABLETS.
MOXIFLOXACIN TABLETS, FOR ORAL USE
INITIAL U.S. APPROVAL: 1999
RECENT MAJOR CHANGES
Dosage and Administration ( 2.2) 5/2020
INDICATIONS AND USAGE
Moxifloxacin tablets are a fluoroquinolone antibacterial indicated for
treating infections in adults 18 years
of age and older caused by designated susceptible bacteria, in the
conditions listed below:
Community Acquired Pneumonia ( 1.1)
Skin and Skin Structure Infections: Uncomplicated ( 1.2) and
Complicated ( 1.3)
Complicated Intra-Abdominal Infections ( 1.4)
Plague ( 1.5)
Acute Bacterial Sinusitis ( 1.6)
Acute Bacterial Exacerbation of Chronic Bronchitis ( 1.7)
To reduce the development of drug-resistant bacteria and maintain the
effectiveness of moxifloxacin
tablets and other antibacterial drugs. Moxifloxacin tablets should be
used only to treat or prevent
infections that are proven or strongly suspected to be caused by
susceptible bacteria. ( 1.8)
DOSAGE AND ADMINISTRATION
TYPE OF INFECTION
DOSE EVERY 24
HOURS
DURATION (DAYS)
Community Acquired Pneumonia ( 1.1)
400 mg
7 to 14
Uncomplicated Skin and Skin Structure Infections (SSSI) ( 1.2)
400 mg
7
Complicated SSSI ( 1.3)
400 mg
7 to 21
Complicated Intra-Abdominal Infections ( 1.4)
400 mg
5 to 14
Plague ( 1.5)
400 mg
10 to 14
Acute Bacterial Sinusitis ( 1.6)
400 mg
10
Acute Bacterial Exacerbation of Chronic Bronchitis ( 1.7)
400 mg
5
No dosage adjustment in patients with renal or hepatic impairment. (
8.6, 8.7)
DOSAGE FORMS AND STRENGTHS
Tablets: 400 mg moxifloxacin ( 3.1)
WARNINGS AND PRECAUTIONS
Prolongation of the QT interval and isolated cases of torsade de
pointes has been reported. Avoid use
in patients with known prolongation, proarrhythmic conditions such as
clinically significant bradycardia
or acute m